1952 (1952) News
Track canonical SquawkNews coverage tagged to 1952, 1952. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Everest Medicines gets NMPA approval for Cardamyst NDA in adult PSVT
Everest Medicines Limited says China’s NMPA approved its Cardamyst (etripamil) NDA for treating PSVT in adults.
GEOPOLITICS | Sep 03, 2026, 03:50 PM UTC
M
Everest Medicines gets NMPA approval for CARDAMYST in adult PSVT
Everest Medicines said China’s NMPA approved CARDAMYST (etripamil) to convert acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults.
GEOPOLITICS | Sep 03, 2026, 03:01 PM UTC